This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Business-in-Brief
Bribery accusations, a new whistleblowing policy, and recalls galore... What’s new for pharma in business?
